v3.26.1
Group Information - Summary of Information about Parent Company (Details)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
BioNTech | AT Impf GmbH    
Disclosure of subsidiaries [line items]    
Ownership of ordinary shares in BioNTech (in %) 40.30% 42.44%